Metraipolis › archive › dc_50447c75cf23
Efficacy and safety of novel antidiabetic drugs in patients with type 2 diabetes and chronic kidney disease: a network meta-analysis — Europe PMC PMID:41987895
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41987895
- DOI
- 10.3389/fendo.2026.1750615
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T15:09:36.405Z
- SHA-256 of the archived text
f3b7e08344492540b57c4bf2246abbda66e8097a663ae94e711d2fe124d969c0- Stable URL of this page
https://metraipolis.com/documento/dc_50447c75cf23
How to cite
Efficacy and safety of novel antidiabetic drugs in patients with type 2 diabetes and chronic kidney disease: a network meta-analysis — Europe PMC PMID:41987895 — Europe PMC (en), https://europepmc.org/article/MED/41987895 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_50447c75cf23 (Metraipolis archive dc_50447c75cf23, sha256 f3b7e08344492540b57c4bf2246abbda66e8097a663ae94e711d2fe124d969c0)
BibTeX
@misc{dc50447c75cf23,
title = {Efficacy and safety of novel antidiabetic drugs in patients with type 2 diabetes and chronic kidney disease: a network meta-analysis — Europe PMC PMID:41987895},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41987895},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_50447c75cf23; sha256 f3b7e08344492540b57c4bf2246abbda66e8097a663ae94e711d2fe124d969c0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41987895. Agents can read the archived copy with the MCP tool read_document.